2023-2028 Global and Regional Hospital-Acquired Disease Testing Industry Status and Prospects Professional Market Research Report Standard Version

Table of Contents

Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2023-2028)

1.4.2 East Asia Market States and Outlook (2023-2028)

1.4.3 Europe Market States and Outlook (2023-2028)

1.4.4 South Asia Market States and Outlook (2023-2028)

1.4.5 Southeast Asia Market States and Outlook (2023-2028)

1.4.6 Middle East Market States and Outlook (2023-2028)

1.4.7 Africa Market States and Outlook (2023-2028)

1.4.8 Oceania Market States and Outlook (2023-2028)

1.4.9 South America Market States and Outlook (2023-2028)

1.5 Global Hospital-Acquired Disease Testing Market Size Analysis from 2023 to 2028

1.5.1 Global Hospital-Acquired Disease Testing Market Size Analysis from 2023 to 2028 by Consumption Volume

1.5.2 Global Hospital-Acquired Disease Testing Market Size Analysis from 2023 to 2028 by Value

1.5.3 Global Hospital-Acquired Disease Testing Price Trends Analysis from 2023 to 2028

1.6 COVID-19 Outbreak: Hospital-Acquired Disease Testing Industry Impact

Chapter 2 Global Hospital-Acquired Disease Testing Competition by Types, Applications, and Top Regions and Countries

2.1 Global Hospital-Acquired Disease Testing (Volume and Value) by Type

2.1.1 Global Hospital-Acquired Disease Testing Consumption and Market Share by Type (2017-2022)

2.1.2 Global Hospital-Acquired Disease Testing Revenue and Market Share by Type (2017-2022)

2.2 Global Hospital-Acquired Disease Testing (Volume and Value) by Application

2.2.1 Global Hospital-Acquired Disease Testing Consumption and Market Share by Application (2017-2022)

2.2.2 Global Hospital-Acquired Disease Testing Revenue and Market Share by Application (2017-2022)

2.3 Global Hospital-Acquired Disease Testing (Volume and Value) by Regions

2.3.1 Global Hospital-Acquired Disease Testing Consumption and Market Share by Regions (2017-2022)

2.3.2 Global Hospital-Acquired Disease Testing Revenue and Market Share by Regions (2017-2022)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2017-2022 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2017-2022 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global Hospital-Acquired Disease Testing Sales, Consumption, Export, Import by Regions (2017-2022)

4.1 Global Hospital-Acquired Disease Testing Consumption by Regions (2017-2022)

4.2 North America Hospital-Acquired Disease Testing Sales, Consumption, Export, Import (2017-2022)

4.3 East Asia Hospital-Acquired Disease Testing Sales, Consumption, Export, Import (2017-2022)

4.4 Europe Hospital-Acquired Disease Testing Sales, Consumption, Export, Import (2017-2022)

4.5 South Asia Hospital-Acquired Disease Testing Sales, Consumption, Export, Import (2017-2022)

4.6 Southeast Asia Hospital-Acquired Disease Testing Sales, Consumption, Export, Import (2017-2022)

4.7 Middle East Hospital-Acquired Disease Testing Sales, Consumption, Export, Import (2017-2022)

4.8 Africa Hospital-Acquired Disease Testing Sales, Consumption, Export, Import (2017-2022)

4.9 Oceania Hospital-Acquired Disease Testing Sales, Consumption, Export, Import (2017-2022)

4.10 South America Hospital-Acquired Disease Testing Sales, Consumption, Export, Import (2017-2022)

Chapter 5 North America Hospital-Acquired Disease Testing Market Analysis

5.1 North America Hospital-Acquired Disease Testing Consumption and Value Analysis

5.1.1 North America Hospital-Acquired Disease Testing Market Under COVID-19

5.2 North America Hospital-Acquired Disease Testing Consumption Volume by Types

5.3 North America Hospital-Acquired Disease Testing Consumption Structure by Application

5.4 North America Hospital-Acquired Disease Testing Consumption by Top Countries

5.4.1 United States Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

5.4.2 Canada Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

5.4.3 Mexico Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

Chapter 6 East Asia Hospital-Acquired Disease Testing Market Analysis

6.1 East Asia Hospital-Acquired Disease Testing Consumption and Value Analysis

6.1.1 East Asia Hospital-Acquired Disease Testing Market Under COVID-19

6.2 East Asia Hospital-Acquired Disease Testing Consumption Volume by Types

6.3 East Asia Hospital-Acquired Disease Testing Consumption Structure by Application

6.4 East Asia Hospital-Acquired Disease Testing Consumption by Top Countries

6.4.1 China Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

6.4.2 Japan Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

6.4.3 South Korea Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

Chapter 7 Europe Hospital-Acquired Disease Testing Market Analysis

7.1 Europe Hospital-Acquired Disease Testing Consumption and Value Analysis

7.1.1 Europe Hospital-Acquired Disease Testing Market Under COVID-19

7.2 Europe Hospital-Acquired Disease Testing Consumption Volume by Types

7.3 Europe Hospital-Acquired Disease Testing Consumption Structure by Application

7.4 Europe Hospital-Acquired Disease Testing Consumption by Top Countries

7.4.1 Germany Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

7.4.2 UK Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

7.4.3 France Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

7.4.4 Italy Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

7.4.5 Russia Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

7.4.6 Spain Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

7.4.7 Netherlands Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

7.4.8 Switzerland Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

7.4.9 Poland Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

Chapter 8 South Asia Hospital-Acquired Disease Testing Market Analysis

8.1 South Asia Hospital-Acquired Disease Testing Consumption and Value Analysis

8.1.1 South Asia Hospital-Acquired Disease Testing Market Under COVID-19

8.2 South Asia Hospital-Acquired Disease Testing Consumption Volume by Types

8.3 South Asia Hospital-Acquired Disease Testing Consumption Structure by Application

8.4 South Asia Hospital-Acquired Disease Testing Consumption by Top Countries

8.4.1 India Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

8.4.2 Pakistan Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

8.4.3 Bangladesh Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

Chapter 9 Southeast Asia Hospital-Acquired Disease Testing Market Analysis

9.1 Southeast Asia Hospital-Acquired Disease Testing Consumption and Value Analysis

9.1.1 Southeast Asia Hospital-Acquired Disease Testing Market Under COVID-19

9.2 Southeast Asia Hospital-Acquired Disease Testing Consumption Volume by Types

9.3 Southeast Asia Hospital-Acquired Disease Testing Consumption Structure by Application

9.4 Southeast Asia Hospital-Acquired Disease Testing Consumption by Top Countries

9.4.1 Indonesia Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

9.4.2 Thailand Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

9.4.3 Singapore Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

9.4.4 Malaysia Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

9.4.5 Philippines Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

9.4.6 Vietnam Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

9.4.7 Myanmar Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

Chapter 10 Middle East Hospital-Acquired Disease Testing Market Analysis

10.1 Middle East Hospital-Acquired Disease Testing Consumption and Value Analysis

10.1.1 Middle East Hospital-Acquired Disease Testing Market Under COVID-19

10.2 Middle East Hospital-Acquired Disease Testing Consumption Volume by Types

10.3 Middle East Hospital-Acquired Disease Testing Consumption Structure by Application

10.4 Middle East Hospital-Acquired Disease Testing Consumption by Top Countries

10.4.1 Turkey Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

10.4.2 Saudi Arabia Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

10.4.3 Iran Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

10.4.4 United Arab Emirates Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

10.4.5 Israel Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

10.4.6 Iraq Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

10.4.7 Qatar Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

10.4.8 Kuwait Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

10.4.9 Oman Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

Chapter 11 Africa Hospital-Acquired Disease Testing Market Analysis

11.1 Africa Hospital-Acquired Disease Testing Consumption and Value Analysis

11.1.1 Africa Hospital-Acquired Disease Testing Market Under COVID-19

11.2 Africa Hospital-Acquired Disease Testing Consumption Volume by Types

11.3 Africa Hospital-Acquired Disease Testing Consumption Structure by Application

11.4 Africa Hospital-Acquired Disease Testing Consumption by Top Countries

11.4.1 Nigeria Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

11.4.2 South Africa Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

11.4.3 Egypt Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

11.4.4 Algeria Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

11.4.5 Morocco Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

Chapter 12 Oceania Hospital-Acquired Disease Testing Market Analysis

12.1 Oceania Hospital-Acquired Disease Testing Consumption and Value Analysis

12.2 Oceania Hospital-Acquired Disease Testing Consumption Volume by Types

12.3 Oceania Hospital-Acquired Disease Testing Consumption Structure by Application

12.4 Oceania Hospital-Acquired Disease Testing Consumption by Top Countries

12.4.1 Australia Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

12.4.2 New Zealand Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

Chapter 13 South America Hospital-Acquired Disease Testing Market Analysis

13.1 South America Hospital-Acquired Disease Testing Consumption and Value Analysis

13.1.1 South America Hospital-Acquired Disease Testing Market Under COVID-19

13.2 South America Hospital-Acquired Disease Testing Consumption Volume by Types

13.3 South America Hospital-Acquired Disease Testing Consumption Structure by Application

13.4 South America Hospital-Acquired Disease Testing Consumption Volume by Major Countries

13.4.1 Brazil Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

13.4.2 Argentina Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

13.4.3 Columbia Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

13.4.4 Chile Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

13.4.5 Venezuela Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

13.4.6 Peru Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

13.4.7 Puerto Rico Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

13.4.8 Ecuador Hospital-Acquired Disease Testing Consumption Volume from 2017 to 2022

Chapter 14 Company Profiles and Key Figures in Hospital-Acquired Disease Testing Business

14.1 Diatherix Laboratories

14.1.1 Diatherix Laboratories Company Profile

14.1.2 Diatherix Laboratories Hospital-Acquired Disease Testing Product Specification

14.1.3 Diatherix Laboratories Hospital-Acquired Disease Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.2 Gen-Probe

14.2.1 Gen-Probe Company Profile

14.2.2 Gen-Probe Hospital-Acquired Disease Testing Product Specification

14.2.3 Gen-Probe Hospital-Acquired Disease Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.3 Qiagen

14.3.1 Qiagen Company Profile

14.3.2 Qiagen Hospital-Acquired Disease Testing Product Specification

14.3.3 Qiagen Hospital-Acquired Disease Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.4 F. Hoffmann-La Roche

14.4.1 F. Hoffmann-La Roche Company Profile

14.4.2 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Product Specification

14.4.3 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.5 Cepheid

14.5.1 Cepheid Company Profile

14.5.2 Cepheid Hospital-Acquired Disease Testing Product Specification

14.5.3 Cepheid Hospital-Acquired Disease Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.6 Life Technologies Corporation

14.6.1 Life Technologies Corporation Company Profile

14.6.2 Life Technologies Corporation Hospital-Acquired Disease Testing Product Specification

14.6.3 Life Technologies Corporation Hospital-Acquired Disease Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.7 Meridian Biosciences

14.7.1 Meridian Biosciences Company Profile

14.7.2 Meridian Biosciences Hospital-Acquired Disease Testing Product Specification

14.7.3 Meridian Biosciences Hospital-Acquired Disease Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.8 Cantel Medical Corporation

14.8.1 Cantel Medical Corporation Company Profile

14.8.2 Cantel Medical Corporation Hospital-Acquired Disease Testing Product Specification

14.8.3 Cantel Medical Corporation Hospital-Acquired Disease Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.9 Nordion

14.9.1 Nordion Company Profile

14.9.2 Nordion Hospital-Acquired Disease Testing Product Specification

14.9.3 Nordion Hospital-Acquired Disease Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)

Chapter 15 Global Hospital-Acquired Disease Testing Market Forecast (2023-2028)

15.1 Global Hospital-Acquired Disease Testing Consumption Volume, Revenue and Price Forecast (2023-2028)

15.1.1 Global Hospital-Acquired Disease Testing Consumption Volume and Growth Rate Forecast (2023-2028)

15.1.2 Global Hospital-Acquired Disease Testing Value and Growth Rate Forecast (2023-2028)

15.2 Global Hospital-Acquired Disease Testing Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)

15.2.1 Global Hospital-Acquired Disease Testing Consumption Volume and Growth Rate Forecast by Regions (2023-2028)

15.2.2 Global Hospital-Acquired Disease Testing Value and Growth Rate Forecast by Regions (2023-2028)

15.2.3 North America Hospital-Acquired Disease Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.4 East Asia Hospital-Acquired Disease Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.5 Europe Hospital-Acquired Disease Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.6 South Asia Hospital-Acquired Disease Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.7 Southeast Asia Hospital-Acquired Disease Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.8 Middle East Hospital-Acquired Disease Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.9 Africa Hospital-Acquired Disease Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.10 Oceania Hospital-Acquired Disease Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.11 South America Hospital-Acquired Disease Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.3 Global Hospital-Acquired Disease Testing Consumption Volume, Revenue and Price Forecast by Type (2023-2028)

15.3.1 Global Hospital-Acquired Disease Testing Consumption Forecast by Type (2023-2028)

15.3.2 Global Hospital-Acquired Disease Testing Revenue Forecast by Type (2023-2028)

15.3.3 Global Hospital-Acquired Disease Testing Price Forecast by Type (2023-2028)

15.4 Global Hospital-Acquired Disease Testing Consumption Volume Forecast by Application (2023-2028)

15.5 Hospital-Acquired Disease Testing Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology